Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05121844 · ClinicalTrials.gov registry record · NA
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
A NA study of PreDiabetes and Weight Loss, sponsored by Signos.
- Active
- Registry status
- NA
- Development phase
- 31,187
- Enrollment target
- 1
- Study location
NCT05121844: Active NA study of PreDiabetes and Weight Loss, sponsored by Signos.
NCT05121844 is a NA study of PreDiabetes and Weight Loss that is active but no longer recruiting, run by Signos. The registered enrollment target is 31,187 participants, above the 492-participant average among 149 other PreDiabetes trials with a reported enrollment target (6239% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05121844, a NA study of PreDiabetes and Weight Loss, is active but no longer recruiting, sponsored by Signos.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 31,187 participants
- Enrollment target
- 1
- Study location
Study Summary
Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity, pre-diabetes and diabetes. Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools that help participants in the pursuit of weight change goals. We hypothesize that the use of CGM data and targeted coaching and nutrition education will assist with weight optimization goals in the general (non-diabetic) population using the Signos mHealth platform, with associated health benefits.
Primary Outcome
Daily fasting glucose, averaged periodically
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitor Device
Study Locations (1)
California
- Signos - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31,187 participants |
| Start Date | 2021-11-02 |
| Est. Completion | 2027-11-01 |
| Phase | NA |
What the registry record for NCT05121844 still lists
NCT05121844 is an interventional study that assigns participants to a tested intervention. Its 31,187 participants enrollment target places it among the larger protocols in the corpus, above the 492-participant average among 149 other PreDiabetes trials with a reported enrollment target (6239% higher).
The record links to 6 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitor Device is the first listed.
NCT05121844 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05121844 about?
NCT05121844 is a clinical study titled "Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform". Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity, p...
What is the current status of trial NCT05121844?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 31,187 participants. The study started on 2021-11-02. Estimated completion is 2027-11-01.
What conditions does trial NCT05121844 study?
This clinical trial studies the following conditions: PreDiabetes, Weight Loss, Metabolic Syndrome, Glucose Intolerance, Central Obesity.
What interventions are being tested in trial NCT05121844?
The interventions under investigation include: Continuous Glucose Monitor Device (DEVICE).
Who is sponsoring clinical trial NCT05121844?
This trial is sponsored by Signos, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05121844 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05121844's enrollment target sits among peer trials
31,187 1st of 149 higher than 149 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI